GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Holdings Corp (XKRX:096760) » Definitions » Current Accrued Expense

JW Holdings (XKRX:096760) Current Accrued Expense : ₩0 Mil (As of Mar. 2025)


View and export this data going back to 2007. Start your Free Trial

What is JW Holdings Current Accrued Expense?

JW Holdings's Current Accrued Expense for the quarter that ended in Mar. 2025 was ₩0 Mil.


JW Holdings Current Accrued Expense Historical Data

The historical data trend for JW Holdings's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JW Holdings Current Accrued Expense Chart

JW Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

JW Holdings Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

JW Holdings Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.


JW Holdings Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of JW Holdings's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


JW Holdings Business Description

Traded in Other Exchanges
N/A
Address
698 Sindaebang 1-dong, Dongjak-gu, Seoul, KOR, 156-010
JW Holdings Corp is a healthcare solutions provider. It is a drug manufacturer based in Korea and its key focus areas are raw material, completion medicine, medical supplies and medical appliances. The company's array of products comprises of antimicrobials, antifungals, anticancer and gastrointestinal agents. It licenses and markets in its home country and in regions such as United States, Japan, Germany, and China.

JW Holdings Headlines

No Headlines